PRP vs Corticosteroid Injections for Shoulder Osteoarthritis
(PRP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial investigates LP-PRP injections for young active duty and civilian patients with shoulder osteoarthritis. The treatment uses concentrated platelets from the patient's own blood to promote healing and reduce inflammation, aiming to improve pain and function without surgery. This method has shown potential in treating various inflammatory and degenerative conditions by modulating the inflammatory environment and promoting tissue repair.
Are You a Good Fit for This Trial?
This trial is for men and women aged 18-70 with shoulder pain from mild to moderate osteoarthritis that hasn't improved with standard treatments. They must not have had recent injections or surgery in the affected shoulder, be pregnant, or have conditions like diabetes, fibromyalgia, chronic fatigue syndrome, or a history of bad reactions to PRP or corticosteroids.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either corticosteroid or platelet-rich plasma injections
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Corticosteroid Injection
- Delayed Platelet Rich Plasma Injection After Corticosteroid Injection Failure
- Platelet Rich Plasma Injection
Corticosteroid Injection is already approved in European Union, United States, Canada for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Walter Reed National Military Medical Center
Lead Sponsor
United States Naval Medical Center, San Diego
Collaborator
Brooke Army Medical Center
Collaborator
Uniformed Services University of the Health Sciences
Collaborator